1-2 of 2
Raffaele Palmieri
Close
Sort by
Journal Articles

RISK-ADAPTED MRD-DIRECTED THERAPY FOR YOUNG ACUTE MYELOID LEUKEMIA ADULTS: 6-YEAR UPDATE OF THE GIMEMA AML1310 TRIAL

Clinical Trials & Observations
Adriano Venditti, Alfonso Piciocchi, Anna Candoni, Valentina Arena, Raffaele Palmieri, Carla Fili, Angelo Michele Carella, Valeria Calafiore, Roberto Cairoli, Paolo De Fabritiis, Gabriella Storti, Prassede Salutari, Francesco Lanza, Giovanni Martinelli, Antonio Curti, Mario Luppi, Claudia Ingrosso, Maria Paola Martelli, Antonio Cuneo, Francesco Albano, Antonino Mulè, Agostino Tafuri, Laura Cudillo, Alessia Tieghi, Nicola Stefano Fracchiolla, Debora Capelli, Silvia Maria Trisolini, Caterina Alati, Edoardo La Sala, Luca Maurillo, Maria Ilaria Del Principe, Maria Antonietta Irno Consalvo, Maria Domenica Divona, Tiziana Ottone, Raffaella Cerretti, Giuseppe Sconocchia, Maria Teresa Voso, Paola Fazi, Marco Vignetti, Francesco Buccisano
Journal: Blood Advances
Blood Adv bloodadvances.2024013182.
https://doi.org/10.1182/bloodadvances.2024013182
Published: 2024
Journal Articles

ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol

Clinical Trials & Observations
Francesco Buccisano, Raffaele Palmieri, Alfonso Piciocchi, Valentina Arena, Anna Candoni, Lorella Melillo, Valeria Calafiore, Roberto Cairoli, Paolo de Fabritiis, Gabriella Storti, Prassede Salutari, Francesco Lanza, Giovanni Martinelli, Mario Luppi, Saveria Capria, Luca Maurillo, Maria Ilaria Del Principe, Giovangiacinto Paterno, Maria Antonietta Irno Consalvo, Tiziana Ottone, Serena Lavorgna, Maria Teresa Voso, Paola Fazi, Marco Vignetti, William Arcese, Adriano Venditti
Journal: Blood Advances
Blood Adv (2022) 6 (8): 2510–2516.
https://doi.org/10.1182/bloodadvances.2021005717
Published: 2022
Includes: Supplemental data